mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action

International Journal of Obesity

Volumn 33, Issue 8, 2009, Pages 842-850

  Koska, J ^a,b   Stefan, N ^c   Dubois, S ^d   Trinidad, C ^a   Considine, R V ^e   Funahashi, T ^f   Bunt, J C ^a   Ravussin, E ^d   Permana, P A ^a,b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Phoenix Veterans Affairs Health Care System   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adipocytes; Adiponectin; Inflammation; Insulin action; MIF; Preadipocytes

Indexed keywords

ADIPONECTIN; GELATINASE A; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE CELL; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BODY FAT; CELL CULTURE; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENE; GENE EXPRESSION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE; HOSPITAL PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IL6 GENE; IL8 GENE; IN VIVO STUDY; INDIAN; INSULIN RESISTANCE; MALE; MCP 1 GENE; MCP 2 GENE; MCP1 GENE; MIF GENE; MIP1ALPHA GENE; MIP2BETA GENE; MMP2 GENE; MULTIVARIATE ANALYSIS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROADIPOCYTE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; ABDOMINAL SUBCUTANEOUS FAT; ADOLESCENT; AMERICAN INDIAN; BLOOD; CROSS-SECTIONAL STUDY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADIPOCYTES; ADOLESCENT; ADULT; CELL SIZE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; INSULIN RESISTANCE; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; OBESITY; RNA, MESSENGER; SUBCUTANEOUS FAT, ABDOMINAL; YOUNG ADULT;

PIMA;

EID: 68949146083     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.106     Document Type: Article

References (41)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
2. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
3. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
4. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-{alpha}, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
5. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
6. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830.
7. Moraes RC, Blondet A, Birkenkamp-Demtroeder K, Tirard J, Orntoft TF, Gertler A et al. Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription- polymerase chain reaction analyses. Endocrinology 2003; 144: 4773-4782.
8. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785-1788.
9. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-2282.
10. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004; 18: 1657-1669.
11. Curat C, Wegner V, Sengenès C, Miranville A, Tonus C, Busse R et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006; 49: 744-747.
12. Lee YH, Nair S, Rousseau E, Allison DB, Page GP, Tataranni PA et al. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia 2005; 48: 1776-1783.
13. Nair S, Lee YH, Rousseau E, Cam M, Tataranni PA, Baier LJ et al. Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia 2005; 48: 1784-1788.
14. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-1033.
15. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000; 43: 1498-1506.
16. Larson-Meyer DE, Heilbronn LK, Redman LM, Newcomer BR, Frisard MI, Anton S et al., the Pennington CALERIE Team. Effect of calorie restriction with or without exercise on insulin sensitivity, {beta}-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 2006; 29: 1337-1344.
17. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96: 88-98.
18. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985; 248 (Part 1): E286-E291.
19. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D et al. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1988; 318: 1217-1225.
20. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 1959; 82: 420-430.
21. Best JD, Taborsky GJ, Halter JB, Porte D. Glucose disposal is not proportional to plasma glucose level in man. Diabetes 1981; 30: 847-850.
22. Lillioja S, Bogardus C. Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev 1988; 4: 517-540.
23. Dubois SG, Heilbronn LK, Smith SR, Albu JB, Kelley DE, Ravussin E. Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity (Silver Spring) 2006; 14: 1543-1552.
24. Smith U, Sjostrom L, Bjornstorp P. Comparison of two methods for determining human adipose cell size. J Lipid Res 1972; 13: 822-824.
25. Trujillo ME, Scherer PE. Adipose tissue-derived factors: impact on health and disease. Endocr Rev 2006; 27: 762-778.
26. Skurk T, Herder C, Kraft I, Muller-Scholze S, Hauner H, Kolb H. Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 2005; 146: 1006-1011.
27. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003; 3: 791-800.
28. Yabunaka N, Nishihira J, Mizue Y, Tsuji M, Kumagai M, Ohtsuka Y et al. Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes. Diabetes Care 2000; 23: 256-258.
29. Herder C, Kolb H, Koenig W, Haastert B, Muller-Scholze S, Rathmann W et al. Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the cooperative health research in the region of Augsburg, survey 4 (KORA S4). Diabetes Care 2006; 29: 368-371.
30. Herder C, Klopp N, Baumert J, Muller M, Khuseyinova N, Meisinger C et al. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Diabetologia 2008; 51: 276-284.
31. Vozarova B, Stefan N, Hanson R, Lindsay RS, Bogardus C, Tataranni PA et al. Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance. Diabetologia 2002; 45: 1739-1741.
32. Juan CC, Chuang TY, Chang CL, Huang SW, Ho LT. Endothelin-1 regulates adiponectin gene expression and secretion in 3T3-L1 adipocytes via distinct signaling pathways. Endocrinology 2007; 148: 1835-1842.
33. Atsumi T, Cho YR, Leng L, McDonald C, Yu T, Danton C et al. The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J Immunol 2007; 179: 5399-5406.
34. Danforth Jr E. Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 2000; 26: 13.
35. Permana PA, Nair S, Lee YH, Luczy-Bachman G, Vozarova de Courten B, Tataranni PA. Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. Am J Physiol Endocrinol Metab 2004; 286: E958-E962.
36. Yang X, Jansson PA, Nagaev I, Jack MM, Carvalho E, Sunnerhagen KS et al. Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun 2004; 317: 1045-1051.
37. Ikeda D, Sakaue S, Kamigaki M, Ohira H, Itoh N, Ohtsuka Y et al. Knockdown of macrophage migration inhibitory factor disrupts adipogenesis in 3T3-L1 cells. Endocrinology 2008; 149: 6037-6042.
38. Sakaue S, Nishihira J, Hirokawa J, Yoshimura H, Honda T, Aoki K et al. Regulation of macrophage migration inhibitory factor (MIF) expression by glucose and insulin in adipocytes in vitro. Mol Med 1999; 5: 361-371.
39. Ruan H, Zarnowski MJ, Cushman SW, Lodish HF. Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J Biol Chem 2003; 278: 47585-47593.
40. Hirsch J, Gallian E. Methods for the determination of adipose cell size in man and animals. J Lipid Res 1968; 9: 110-119.
41. Hother-Nielsen O, Henriksen JE, Holst JJ, Beck-Nielsen H. Effects of insulin on glucose turnover rates in vivo: Isotope dilution versus constant specific activity technique. Metabolism 1996; 45: 82-91.